Studies have shown that CD133+ cells isolated from uterine carcinosarcomas have properties of cancer stem cells such as differentiation into both epithelial and stromal lineages, chemotherapy resistance, increased expression of stem cell markers including BMI1, and in vivo transplantable tumors [42]. The gene discussed is BMI1; the disease is uterine carcinosarcoma.